GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,644 | +38.8% | 44,000 | +100.0% | 0.00% | -50.0% |
| Q2 2023 | $26,400 | -4.8% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $27,720 | +265.0% | 22,000 | +528.6% | 0.00% | +100.0% |
| Q4 2022 | $7,595 | -81.9% | 3,500 | 0.0% | 0.00% | -75.0% |
| Q3 2022 | $42,000 | +44.8% | 3,500 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $29,000 | -3.3% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -25.0% | 3,500 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $40,000 | -9.1% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $44,000 | +57.1% | 3,500 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $28,000 | -12.5% | 3,500 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $32,000 | -5.9% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $34,000 | +183.3% | 3,500 | +250.0% | 0.00% | +200.0% |
| Q3 2020 | $12,000 | -7.7% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $13,000 | +30.0% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |